Prolonged and repeated courses of OKT3 after liver transplantation.
Colledan
M
M
Centro per il Trapianto di Fegato, Ospedale Maggiore di Milano, Italy.
Gridelli
B
B
Rossi
G
G
Caccamo
L
L
Gatti
S
S
Bonara
P
P
Fassati
L R
LR
Ferla
G
G
Maggi
U
U
Reggiani
P
P
D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000627:therapeutic use*; D015703:Antigens, CD / Q000032:analysis; D000945:Antigens, Differentiation, T-Lymphocyte / Q000032:analysis; D017252:CD3 Complex; D003131:Combined Modality Therapy; D003524:Cyclosporins / Q000627:therapeutic use; D004334:Drug Administration Schedule; D005434:Flow Cytometry; D006084:Graft Rejection; D006801:Humans; D007165:Immunosuppression Therapy; D016031:Liver Transplantation / Q000276:immunology*; D008214:Lymphocytes / Q000276:immunology; D016853:Muromonab-CD3; D011948:Receptors, Antigen, T-Cell / Q000032:analysis
D000911:Antibodies, Monoclonal; D015703:Antigens, CD; D000945:Antigens, Differentiation, T-Lymphocyte; D017252:CD3 Complex; D003524:Cyclosporins; D016853:Muromonab-CD3; D011948:Receptors, Antigen, T-Cell